RxSight, Inc. RXST Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.89M-5.3% | $32.61M+7.5% | $30.34M-9.8% | $33.64M-11.2% | $37.9M-5.8% | ||
| $7.4M+0.7% | $7.35M+20.2% | $6.11M-27.6% | $8.45M-11.7% | $9.57M-16.3% | ||
| $23.5M-7.0% | $25.26M+4.3% | $24.23M-3.8% | $25.19M-11.1% | $28.33M-1.6% | ||
| 76.1%-1.4pp | 77.5%-2.4pp | 79.9%+5.0pp | 74.9%+0.1pp | 74.8%+3.2pp | ||
| $9.47M+6.4% | $8.91M-1.7% | $9.06M-11.3% | $10.22M-1.4% | $10.37M+12.6% | ||
| $31.86M+15.0% | $27.7M+1.3% | $27.35M-5.6% | $28.98M+1.2% | $28.64M+1.5% | ||
| $41.33M+12.9% | $36.6M+0.5% | $36.41M-7.1% | $39.19M+0.5% | $39M+4.2% | ||
| $41.33M+12.9% | $36.6M+0.5% | $36.41M-7.1% | $39.19M+0.5% | $39M+4.2% | ||
| -$17.83M-57.3% | -$11.34M+6.9% | -$12.18M+13.0% | -$14M-31.2% | -$10.67M-23.7% | ||
| -57.7%-22.9pp | -34.8%+5.4pp | -40.1%+1.5pp | -41.6%-13.5pp | -28.2%-6.7pp | ||
| $3K-40.0% | $5K+25.0% | $4K-20.0% | $5K-16.7% | $6K+20.0% | ||
| $1.95M-11.0% | $2.2M-7.6% | $2.38M+5.4% | $2.25M-10.1% | $2.51M-7.4% | ||
| -$15.88M-73.6% | -$9.15M+6.7% | -$9.81M+16.6% | -$11.75M-43.8% | -$8.17M-37.9% | ||
| $6K+20.0% | $5K-50.0% | $10K-68.8% | $32K+77.8% | $18K+50.0% | ||
| -$15.88M-73.6% | -$9.15M+6.8% | -$9.82M+16.7% | -$11.79M-43.9% | -$8.19M-37.9% | ||
| -51.4%-23.3pp | -28.1%+4.3pp | -32.4%+2.7pp | -35%-13.4pp | -21.6%-6.8pp | ||
| -$0.38-72.7% | -$0.22+8.3% | -$0.24+17.2% | -$0.29-45.0% | -$0.20-33.3% | ||
| -$0.38-72.7% | -$0.22+8.3% | -$0.24+17.2% | -$0.29-45.0% | -$0.20-33.3% | ||
| 41.3M+1.1% | 40.9M-0.3% | 41M+0.5% | 40.7M+0.6% | 40.5M+4.2% | ||
| 41.3M+1.1% | 40.9M-0.3% | 41M+0.5% | 40.7M+0.6% | 40.5M+4.2% | ||
| -$16M-74.7% | -$9.16M+5.0% | -$9.64M+19.1% | -$11.92M-42.9% | -$8.34M-32.5% | ||
| $1.95M-11.0% | $2.2M-7.6% | $2.38M+5.4% | $2.25M-10.1% | $2.51M-7.4% | ||
| $30.89M-5.3% | $32.61M+7.5% | $30.34M-9.8% | $33.64M-11.2% | $37.9M-5.8% | ||
| -$17.83M-57.3% | -$11.34M+6.9% | -$12.18M+13.0% | -$14M-31.2% | -$10.67M-23.7% | ||
| -$17M-62.1% | -$10.49M+7.4% | -$11.32M+14.3% | -$13.22M-33.5% | -$9.9M-22.0% | ||
| -$17M-62.1% | -$10.49M+7.4% | -$11.32M+14.3% | -$13.22M-33.5% | -$9.9M-22.0% | ||
| -55%-22.9pp | -32.2%+5.2pp | -37.3%+2.0pp | -39.3%-13.2pp | -26.1%-5.9pp | ||
| -$17.83M-57.3% | -$11.34M+6.9% | -$12.18M+13.0% | -$14M-31.2% | -$10.67M-23.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is RxSight, Inc.'s revenue?
- RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.
- Is RxSight, Inc. profitable?
- RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.
- What are RxSight, Inc.'s profit margins?
- Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.
- What is RxSight, Inc.'s earnings per share?
- RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
- Where does RxSight, Inc.'s income statement data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
